The Effect of Acupressure on Shoulder Pain and Breastfeeding Self-efficacy
1 other identifier
interventional
90
0 countries
N/A
Brief Summary
In this study, for the first time in our country, acupressure will be examined on post-cesarean shoulder pain and breastfeeding self-efficacy by using a combination of shoulder (GB21), hand (LI4) and leg (ST36) points and applying acupressure as repeated sessions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2023
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2023
CompletedFirst Posted
Study publicly available on registry
February 15, 2023
CompletedStudy Start
First participant enrolled
February 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2023
CompletedFebruary 15, 2023
February 1, 2023
3 months
January 30, 2023
February 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Comparison Scale (Visual Analog Scale (VAS))
In the evaluation of VAS, 0 mm = no pain, 100 mm refers to unbearable pain. On the scale, 0-44 mm shows mild pain, 45-74 mm shows moderate pain, and 75-100 mm shows severe pain
one day
Secondary Outcomes (2)
Verbal Category Scale (SCS)
one day
BREASTFEEDING SELF-EFFICACY SCALE SHORT FORM
one day
Study Arms (2)
acupressure group
EXPERIMENTALAcupressure will be performed by the researchers of the main, hand and body parts of the women in the experimental units.In the clinic where the study will be conducted, acupressure application hours were determined considering the analgesic treatment protocol applied. Acupressure will be applied at the 18th and 24th hours postpartum.
control group
NO INTERVENTIONAcupressure will not be applied to the control group. routine midwifery care.
Interventions
Acupressure will be applied to the shoulders, hands and legs of the women in the experimental group by the researcher.
Eligibility Criteria
You may qualify if:
- Those whose pain intensity is 45 mm or more according to the Vision Analogue Scale (VAS),
- Those who are disturbing and above according to the verbal category scale (SCS),
- Cesarean delivery by applying spinal anesthesia,
- who has an outdated, single and healthy newborn,
- weeks of gestation,
- Between 18 and 45 years old,
- No fractures or dislocations in the shoulder,
- The absence of chronic pain in the shoulder,
- No history of trauma on the shoulder,
- No systemic and chronic diseases,
- No communication problems
- Women who agree to participate in the study will be sampled.
You may not qualify if:
- Cesarean delivery with general anesthesia
- Shoulder pain before cesarean section,
- Those who develop any complications related to the mother and the baby in the postpartum period (bleeding, hypertension, babies taken to the neonatal intensive care unit, etc.),
- Have a body mass index above 25 kg/m2,
- Have previous acupressure experience,
- Patients who consume caffeine (tea, coffee, chocolate...),
- If necessary, patients who underwent analgesia will not be included in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kübra Türkben
kturkben@agri.edu.tr
Central Study Contacts
Meral Kılıç
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- research assistant
Study Record Dates
First Submitted
January 30, 2023
First Posted
February 15, 2023
Study Start
February 20, 2023
Primary Completion
May 31, 2023
Study Completion
May 31, 2023
Last Updated
February 15, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share